HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on AC Immune (NASDAQ:ACIU) and maintained a $16 price target.
March 15, 2024 | 10:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Andrew Fein reiterated a Buy rating on AC Immune with a $16 price target.
The reiteration of a Buy rating and maintenance of a $16 price target by a reputable analyst suggests a positive outlook for AC Immune's stock. This endorsement could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100